Contact – +1-276-477-5910
 Email – [email protected]

Home >>

Healthcare and Social Assistance

>>

Global Genome Sequencing Market


Global Genome Sequencing Market 2020-2030 by Product (Consumables, Sequencers & Software, Service), Technology (PCR, Sequencing, Microarray), Application, End User, and Region: Trend Forecast and Growth Opportunity

Report code: SDMRHE1613141 | Industry: Healthcare and Social Assistance | Published On: 2022-01-07


Global genome sequencing market will reach $24.37 billion by 2030, growing by 12.6% annually over 2020-2030, driven by the growing government funding to encourage genomics projects, the increasing of the incidence of the cancer and the increasing applications of next-generation sequencing, and the utilization of genomics in specialized or personalized medicine.
Highlighted with 82 tables and 85 figures, this 165-page report “Global Genome Sequencing Market 2020-2030 by Product (Consumables, Sequencers & Software, Service), Technology (PCR, Sequencing, Microarray), Application, End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global genome sequencing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19).
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global genome sequencing market in every aspect of the classification from perspectives of Product, Technology, Application, End User, and Region.

Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Consumables
• Sequencers & Software
• Service

Based on Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Polymerase Chain Reaction (PCR)
• Sequencing
• Microarray
• Nucleic Acid Extraction and Purification
• Other Technologies

Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Diagnostics
o Oncology
o Reproductive Health
o Complex Disease Research
o Other Diagnostics
• Drug Discovery and Development
• Precision Medicine
• Agriculture and Animal Research
• Other Applications

By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Academic & Research Centers
• Pharmaceutical and Biotechnology Companies
• Consumer Genomic Service Providers
• Government Institutes
• Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, Other Nations)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product, Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
BGI
Biomatters
Bio-Rad Laboratories, Inc.
DNASTAR
F. Hoffmann-La Roche
Illumina, Inc.
Macrogen Inc.
Myriad Genetics, Inc.
New England Biolabs
Oxford Nanopore Technology
PerkinElmer Inc.
Qiagen
Siemens Healthineers
Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1  Introduction 9
1.1  Industry  Definition  and  Research  Scope 9
1.1.1  Industry  Definition 9
1.1.2  Research  Scope 10
1.2  Research  Methodology 13
1.2.1  Overview  of  Market  Research  Methodology 13
1.2.2  Market  Assumption 14
1.2.3  Secondary  Data 14
1.2.4  Primary  Data 14
1.2.5  Data  Filtration  and  Model  Design 15
1.2.6  Market  Size/Share  Estimation 16
1.2.7  Research  Limitations 17
1.3  Executive  Summary 18
2  Market  Overview  and  Dynamics 21
2.1  Market  Size  and  Forecast 21
2.1.1  Impact  of  COVID-19  on  World  Economy 22
2.1.2  Impact  of  COVID-19  on  the  Market 25
2.2  Major  Growth  Drivers 27
2.3  Market  Restraints  and  Challenges 34
2.4  Emerging  Opportunities  and  Market  Trends 37
2.5  Porter’s  Fiver  Forces  Analysis 41
3  Segmentation  of  Global  Market  by  Product 45
3.1  Market  Overview  by  Product 45
3.2  Consumables 47
3.3  Sequencers  &  Software 48
3.4  Service 49
4  Segmentation  of  Global  Market  by  Technology 50
4.1  Market  Overview  by  Technology 50
4.2  Polymerase  Chain  Reaction  (PCR) 52
4.3  Sequencing 53
4.4  Microarray 54
4.5  Nucleic  Acid  Extraction  and  Purification 55
4.6  Other  Technologies 56
5  Segmentation  of  Global  Market  by  Application 57
5.1  Market  Overview  by  Application 57
5.2  Diagnostics 59
5.2.1  Oncology 61
5.2.2  Reproductive  Health 62
5.2.3  Complex  Disease  Research 63
5.2.4  Other  Diagnostics 64
5.3  Drug  Discovery  and  Development 65
5.4  Precision  Medicine 66
5.5  Agriculture  and  Animal  Research 67
5.6  Other  Applications 68
6  Segmentation  of  Global  Market  by  End  User 69
6.1  Market  Overview  by  End  User 69
6.2  Academic  &  Research  Centers 71
6.3  Pharmaceutical  and  Biotechnology  Companies 72
6.4  Consumer  Genomic  Service  Providers 73
6.5  Government  Institutes 74
6.6  Other  End  Users 75
7  Segmentation  of  Global  Market  by  Region 76
7.1  Geographic  Market  Overview  2019-2030 76
7.2  North  America  Market  2019-2030  by  Country 80
7.2.1  Overview  of  North  America  Market 80
7.2.2  U.S. 84
7.2.3  Canada 87
7.2.4  Mexico 89
7.3  European  Market  2019-2030  by  Country 91
7.3.1  Overview  of  European  Market 91
7.3.2  Germany 95
7.3.3  U.K. 97
7.3.4  France 99
7.3.5  Spain 101
7.3.6  Italy 103
7.3.7  Russia 105
7.3.8  Rest  of  European  Market 107
7.4  Asia-Pacific  Market  2019-2030  by  Country 109
7.4.1  Overview  of  Asia-Pacific  Market 109
7.4.2  Japan 113
7.4.3  China 116
7.4.4  Australia 118
7.4.5  India 120
7.4.6  South  Korea 122
7.4.7  Rest  of  APAC  Region 124
7.5  South  America  Market  2019-2030  by  Country 126
7.5.1  Argentina 129
7.5.2  Brazil 131
7.5.3  Chile 133
7.5.4  Rest  of  South  America  Market 135
7.6  MEA  Market  2019-2030  by  Country 136
7.6.1  UAE 139
7.6.2  Saudi  Arabia 141
7.6.3  South  Africa 143
7.6.4  Other  National  Markets 145
8  Competitive  Landscape 146
8.1  Overview  of  Key  Vendors 146
8.2  New  Product  Launch,  Partnership,  Investment,  and  M&A 149
8.3  Company  Profiles 150
BGI 150
Biomatters 152
Bio-Rad  Laboratories,  Inc. 153
DNASTAR 154
F.  Hoffmann-La  Roche 155
Illumina,  Inc. 156
Macrogen  Inc. 157
Myriad  Genetics,  Inc. 158
New  England  Biolabs 159
Oxford  Nanopore  Technology 160
PerkinElmer  Inc. 161
Qiagen 162
Siemens  Healthineers 163
Thermo  Fisher  Scientific 164
RELATED  REPORTS 165
For more information, please contact [email protected]
 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT